AI Article Synopsis
- Renovascular hypertension from renal artery stenosis (RAS) affects 3-5% of hypertension cases, with this study focusing on the genetic aspect of the condition.
- The research involved 36 patients undergoing tests for atherosclerotic renovascular hypertension, utilizing methods like arteriography and genetic analysis to assess the SNP rs198389 polymorphism in the BNP gene.
- Findings indicated that patients with the C allele of the BNP gene are more likely to have severe RAS, suggesting a link between this genetic variation and the severity of atherosclerotic lesions in the renal arteries.
Article Abstract
Introduction: Renovascular hypertension caused by renal artery stenosis (RAS) accounts for 3-5% of all cases of hypertension.
Objectives: The aim of the study was to determine the association between SNP rs198389 (T-381 C) polymorphism in the B-type natriuretic peptide promoter (BNP) gene and the degree of RAS in patients with atherosclerotic renovascular hypertension.
Patients And Methods: Thirty-six patients scheduled for invasive diagnostic evaluation of atherosclerotic renovascular hypertension were enrolled in the study. Arteriography was performed through a femoral artery access. In order to identify SNP rs198389 (T-381 C) polymorphism in the BNP gene genotyping was performed using genomic DNA isolated from peripheral blood leukocytes. Amplified by polymerase chain reaction and purified product was used to minisequencing. Capillary electrophoresis was applied to separate and detect minisequencing products. The analysis enabled to discriminate TC heterozygotes, TT homozygotes, and CC homozygotes at position 381 of the BNP gene promoter.
Results: Patients homozygous for C allele occurred more frequently in patients with high-grade RAS in comparison with the moderate and mild stenosis groups. TT homozygotes were observed more frequently in mild stenosis patients compared to the moderate and high-grade stenosis groups. None of the patients who had mild RAS was homozygous for C allele and none of the patients who had severe RAS was homozygous for T allele.
Conclusions: We demonstrated the association between SNP rs198389 (T-381 C) polymorphism in the BNP gene promoter and the degree of RAS in patients with atherosclerotic renovascular hypertension. It appears that subjects homozygous for C allele at position 381 of the BNP precursor gene promoter are more prone to develop atherosclerotic lesions in renal arteries.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Circulating N-Terminal Probrain Natriuretic Peptide Levels in Relation to Ischemic Stroke and Its Subtypes: A Mendelian Randomization Study.
Front Genet
February 2022
China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Mendelian randomization was used to evaluate the potential causal association between N-terminal probrain natriuretic peptide (NT-proBNP) and ischemic stroke based on summary statistics data from large-scale genome-wide association studies. Three single-nucleotide polymorphisms (SNPs) rs198389, rs13107325, and rs11105306 associated with NT-proBNP levels found in large general populations and in patients with acute heart disease were used as instrumental variables. The results of genetic association analysis of each single SNP show that there is no significant association between NT-proBNP levels and ischemic stroke or its subtypes, whereas rs198389 alone has a suggestive association with large-artery atherosclerosis stroke.
View Article and Find Full Text PDFSTOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure.
JACC Basic Transl Sci
June 2021
STOP-HF Unit, St Vincent's University Healthcare Group, Dublin, Ireland.
B-type natriuretic peptide (BNP) possesses blood-pressure-lowering, antifibrotic, and aldosterone-suppressing properties. In Stage A and B heart failure, the carriers of the minor C allele of the BNP genetic variant rs198389 have higher circulating levels of BNP and are at decreased risk of hypertension, new-onset left ventricular systolic dysfunction, and hospitalization for major adverse cardiovascular events. Future studies are warranted to investigate the role of BNP genetic testing and BNP-based therapy in the prevention of heart failure.
View Article and Find Full Text PDFSex Differences of the Natriuretic Peptide Polymorphism Associated With Angiographic Coronary Atherosclerosis.
Cardiol Res
February 2017
Department of Biomedical and Molecular Sciences, Queen's University, 18 Stuart Street, Kingston, ON, Canada; Division of Cardiology, Department of Medicine, Queen's University, 94 Stuart Street, Kingston, ON, Canada.
Background: Polymorphisms within natriuretic peptide (NP) genes have been associated with clinical outcomes for cardiovascular disease (CVD), but no previous study has compared the effect of these polymorphisms between men and women. This study aimed to investigate the association between single nucleotide polymorphisms (SNPs) in key genes of the NP system and coronary angiographic outcomes, with the focus on the sexual dimorphism in the effects of these SNPs.
Methods: Patients undergoing clinically indicated coronary angiography (n = 513, 328 men and 185 women) were consented and genotyped for rs5065, rs198389 and rs10758325.
N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a strong predictor of mortality in coronary artery disease and is widely employed as a prognostic biomarker. However, a causal relationship between NT-proBNP and clinical endpoints has not been established. We have performed a genome-wide association and Mendelian randomization study of NT-proBNP.
View Article and Find Full Text PDFCorrelation between rs198388 and rs198389 polymorphismsin brainnatriuretic peptide (NPPB) gene and susceptibility to congenital heart diseases in a Chinese population.
Int J Clin Exp Med
January 2016
Department of Cardiology, Medical College Affiliated Children Hospital, Zhejiang University Hangzhou 310002, China.
Objective: We discussed the correlation between SNP loci (rs198389 and rs198388) in brain natriuretic peptide gene (NPPB) and susceptibility to congenital heart diseases (CHD).
Method: Multiplex SNaPshot technique was adopted for profiling of SNP genotypes at loci rs198389 and rs198388 in NPPB gene among 150 cases of CHDand 150 normal controls.
Results: The distribution frequency of 3 genotypes (AA, AG and GG) at locus rs198389 was 40.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!